Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Starting retirement planning at 60 can present unique challenges. Learn how to effectively navigate this stage for a secure future.
20,891 articlesViking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Chipotle stock topped market today as investors cheered a mix of global expansion news, digital growth, and improving...
When a large hedge fund reduces its Celcuity stake, markets pay attention. This article breaks down the move, what it...
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
Micron’s stock has surged dramatically in the last year. While some analysts see meaningful upside from current level...
Netflix just posted a record quarterly revenue, but the forecast for the next quarter came in softer than expected. H...
Beachbody's 2025 earnings shed light on how fitness brands monetize digital subscriptions, gear, and licensing. This ...
SkyX’s Q1 2026 results hint at a company in transition: solid top-line momentum paired with ongoing investments. This...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
An AI-driven crypto benchmark echoes a cautionary tale: even with time and resources, strategic missteps can trigger ...
A major fund recently disclosed a large move in Globalstar as the stock surged. This article explains what happened, ...